These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 32565086)

  • 1. How Do Type of Preoperative P2Y
    Voetsch A; Pregartner G; Berghold A; Seitelberger R; Schoerghuber M; Toller W; Mahla E
    Ann Thorac Surg; 2021 Jan; 111(1):77-84. PubMed ID: 32565086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of P2Y12 receptor antagonists on platelet function and clinical outcomes in patients undergoing Primary PCI: A substudy of the HEAT-PPCI trial.
    Shahzad A; Khanna V; Kemp I; Shaw M; Mars C; Cooper R; Wilson K; Curzen N; Stables RH
    EuroIntervention; 2018 Mar; 13(16):1931-1938. PubMed ID: 29336311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bleeding in Patients Treated With Ticagrelor or Clopidogrel Before Coronary Artery Bypass Grafting.
    Holm M; Biancari F; Khodabandeh S; Gherli R; Airaksinen J; Mariscalco G; Gatti G; Reichart D; Onorati F; De Feo M; Santarpino G; Rubino AS; Maselli D; Santini F; Nicolini F; Zanobini M; Kinnunen EM; Ruggieri VG; Perrotti A; Rosato S; Dalén M
    Ann Thorac Surg; 2019 Jun; 107(6):1690-1698. PubMed ID: 30898561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet inhibitor withdrawal and outcomes after coronary artery surgery: an individual patient data meta-analysis.
    Schoerghuber M; Kuenzer T; Biancari F; Dalén M; Hansson EC; Jeppsson A; Schlachtenberger G; Siegemund M; Voetsch A; Pregartner G; Lindenau I; Zimpfer D; Berghold A; Mahla E; Zirlik A
    Eur J Cardiothorac Surg; 2024 Jul; 66(1):. PubMed ID: 38970368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Ticagrelor Versus Clopidogrel on Bleeding Outcomes of Isolated Coronary Artery Bypass Grafting.
    Ingrassia JJ; Mosleh W; Conner CM; Mather JF; Loya DS; Yaffee DW; Sutton TS; Takata ET; McMahon SR; Hashim SW; McKay RG
    Cardiovasc Revasc Med; 2023 Jan; 46():44-51. PubMed ID: 35961855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention Receiving an Oral Anticoagulant and Dual Antiplatelet Therapy: A Comparison of Clopidogrel Versus Prasugrel From the TRANSLATE-ACS Study.
    Jackson LR; Ju C; Zettler M; Messenger JC; Cohen DJ; Stone GW; Baker BA; Effron M; Peterson ED; Wang TY
    JACC Cardiovasc Interv; 2015 Dec; 8(14):1880-9. PubMed ID: 26718518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends for and Clinical Factors Associated with Choice of Oral P2Y
    Jain N; Hunt SL; Cui H; Phadnis MA; Mahnken JD; Shireman TI; Dai J; Mehta JL; Rasu RS
    Cardiovasc Drugs Ther; 2019 Oct; 33(5):511-521. PubMed ID: 31729588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of ex vivo autologous and in vivo platelet transfusion in the reversal of P2Y12 inhibition by clopidogrel, prasugrel, and ticagrelor: the APTITUDE study.
    O'Connor SA; Amour J; Mercadier A; Martin R; Kerneis M; Abtan J; Brugier D; Silvain J; Barthélémy O; Leprince P; Montalescot G; Collet JP;
    Circ Cardiovasc Interv; 2015 Nov; 8(11):e002786. PubMed ID: 26553698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights from In Vitro and Clinical Data to Guide Transition from the Novel P2Y12 Antagonist Selatogrel to Clopidogrel, Prasugrel, and Ticagrelor.
    Schilling U; Dingemanse J; Dobrow M; Baumann M; Riederer MA; Juif PE; Ufer M
    Thromb Haemost; 2021 Jun; 121(6):755-766. PubMed ID: 33412611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precatheterization Use of P2Y
    Badri M; Abdelbaky A; Li S; Chiswell K; Wang TY
    J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28939715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does Platelet Reactivity Predict Bleeding in Patients Needing Urgent Coronary Artery Bypass Grafting During Dual Antiplatelet Therapy?
    Mahla E; Prueller F; Farzi S; Pregartner G; Raggam RB; Beran E; Toller W; Berghold A; Tantry US; Gurbel PA
    Ann Thorac Surg; 2016 Dec; 102(6):2010-2017. PubMed ID: 27378554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency, Reasons, and Impact of Premature Ticagrelor Discontinuation in Patients Undergoing Coronary Revascularization in Routine Clinical Practice: Results From the Bern Percutaneous Coronary Intervention Registry.
    Zanchin T; Temperli F; Karagiannis A; Zanchin C; Räsänen M; Koskinas KC; Stortecky S; Hunziker L; Praz F; Blöchlinger S; Moro C; Moschovitis A; Seiler C; Billinger M; Heg D; Pilgrim T; Valgimigli M; Windecker S; Räber L
    Circ Cardiovasc Interv; 2018 May; 11(5):e006132. PubMed ID: 29748219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review with meta-analysis: the risk of gastrointestinal bleeding in patients taking third-generation P2Y
    Guo CG; Chen L; Chan EW; Cheung KS; Isshiki T; Wong ICK; Leung WK
    Aliment Pharmacol Ther; 2019 Jan; 49(1):7-19. PubMed ID: 30506985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: Insights from the RENAMI registry.
    D'Ascenzo F; Bertaina M; Fioravanti F; Bongiovanni F; Raposeiras-Roubin S; Abu-Assi E; Kinnaird T; Ariza-Solé A; Manzano-Fernández S; Templin C; Velicki L; Xanthopoulou I; Cerrato E; Rognoni A; Boccuzzi G; Omedè P; Montabone A; Taha S; Durante A; Gili S; Magnani G; Autelli M; Grosso A; Blanco PF; Garay A; Quadri G; Varbella F; Queija BC; Paz RC; Fernández MC; Pousa IM; Gallo D; Morbiducci U; Dominguez-Rodriguez A; Valdés M; Cequier A; Alexopoulos D; Iñiguez-Romo A; Gaita F; Rinaldi M; Lüscher TF
    Eur J Prev Cardiol; 2020 May; 27(7):696-705. PubMed ID: 30862233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Third-Generation P2Y12 Inhibitors in East Asian Acute Myocardial Infarction Patients: A Nationwide Prospective Multicentre Study.
    Kang J; Han JK; Ahn Y; Chae SC; Kim YJ; Chae IH; Hur SH; Seong IW; Chae JK; Cho MC; Seung KB; Jeong MH; Yang HM; Park KW; Kang HJ; Koo BK; Kim HS;
    Thromb Haemost; 2018 Mar; 118(3):591-600. PubMed ID: 29534250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triple Antithrombotic Therapy With Aspirin, P2Y12 Inhibitor, and Warfarin After Percutaneous Coronary Intervention: An Evaluation of Prasugrel or Ticagrelor Versus Clopidogrel.
    Verlinden NJ; Coons JC; Iasella CJ; Kane-Gill SL
    J Cardiovasc Pharmacol Ther; 2017 Nov; 22(6):546-551. PubMed ID: 28279076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized Comparison of Oral P2Y
    Hochholzer W; Kleiner P; Younas I; Valina CM; Löffelhardt N; Amann M; Bömicke T; Ferenc M; Hauschke D; Trenk D; Neumann FJ; Stratz C
    JACC Cardiovasc Interv; 2017 Jan; 10(2):121-129. PubMed ID: 28104204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ischemic and bleeding outcomes after coronary artery bypass grafting among patients initially treated with a P2Y
    Russo JJ; James TE; Ruel M; Dupuis JY; Singh K; Goubran D; Malhotra N; Rubens F; Chong AY; Hibbert B; Boland P; Tran DT; Tanguay JF; Lordkipanidzé M; Perrault L; Wells GA; Bourke M; Chan V; So DY
    Eur Heart J Acute Cardiovasc Care; 2019 Sep; 8(6):543-553. PubMed ID: 29313713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How do type of preoperative P2Y
    Schoerghuber M; Pregartner G; Berghold A; Lindenau I; Zweiker R; Voetsch A; Mahla E; Zirlik A
    BMJ Open; 2022 Mar; 12(3):e060404. PubMed ID: 35351733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is platelet function testing at the acute phase under P2Y
    Bal Dit Sollier C; Berge N; Hamadouche S; Brumpt C; Stepanian A; Henry P; Siguret V; Drouet L; Dillinger JG
    Arch Cardiovasc Dis; 2021 Oct; 114(10):612-623. PubMed ID: 34275780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.